Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model

Gynecologic Oncology

Volumn 87, Issue 1, 2002, Pages 64-70

  Chan, John K ^b   Monk, Bradley J ^b   Cuccia, David ^a   Pham, Huyen ^b   Kimel, Sol ^a,c   Gu, Mai ^b   Hammer Wilson, Marie J ^a   Liaw, Lih Huei L ^a   Osann, Kathryn ^b   DiSaia, Philip J ^b   Berns, Michael ^a   Tromberg, Bruce ^a   Tadir, Yona ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER SIZE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; INTERMETHOD COMPARISON; LAPAROSCOPY; METASTASIS; NONHUMAN; OVARY CARCINOMA; PHOTODYNAMICS; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; TUMOR BIOPSY;

EID: 0036929821     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6793     Document Type: Article

References (31)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51(1):15-36.
2. DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology. 5th Ed. St. Louis: Mosby, 2002.
3. Sugiyama T, Nishida T, Komai K, Nishimura H, Yakushiji M. Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer. Int J Gynaecol Obstet 1996;54(3):251-6.
4. Creasman WT, Eddy GL. Prognostic factors in relation to second-look laparotomy in ovarian cancer. Baillieres Clin Obstet Gynaecol 1989;3(1): 183-90.
5. Pectasides D, Kayianni H, Facou A, et al. Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patients. Am J Clin Oncol 1991;14(6):457-62.
6. Clarke-Pearson DL, Bandy LC, Dudzinski M, Heaston D, Creasman WT. Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings. J Am Med Assoc 1986;255(5):627-30.
7. Rose PG, Faulhaber P, Miraldi F, Abdul-Karim FW. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: Correlation with second-look laparotomy. Gynecol Oncol 2001;82(1):17-21.
8. Selman AE, Copeland LJ. The roles of second-look laparotomy and cancer antigen 125 in the management of ovarian carcinoma. Curr Oncol Rep 1999;1(1):71-6.
9. Morrow CP. An opinion in support of second-look surgery in ovarian cancer. Gynecol Oncol 2000;79(3):341-3.
10. Clough KB, Ladonne JM, Nos C, Renolleau C, Validire P, Durand JC. Second look for ovarian cancer: Laparoscopy or laparotomy? A prospective comparative study. Gynecol Oncol 1999;72(3):411-7.
11. Ozols RF, Fisher RI, Anderson T, Makuch R, Young RC. Peritoneoscopy in the management of ovarian cancer. Am J Obstet Gynecol 1981;140(6): 611-9.
12. Lin CW. Photodynamic therapy of malignant tumors - Recent developments. Cancer Cells 1991;3(11):437-44.
13. Pass HI. Photodynamic therapy in oncology: Mechanisms and clinical use. J Natl Cancer Inst 1993;85(6):443-56.
14. Orth K, Russ D, Steiner R, Beger HG. Fluorescence detection of small gastrointestinal tumours: Principles, technique, first clinical experience. Langenbecks Arch Surg 2000;385(7):488-94.
15. Ladner DP, Steiner RA, Allernann J, Haller U, Walt H. Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid. Br J Cancer 2001;84(1):33-7.
16. Lange N, Jichlinski P, Zellweger M, et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: A pilot study. Br J Cancer 1999;80(1-2):185-93.
17. Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S, Shulman DG. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Current clinical and development status. J Clin Laser Med Surg 1996; 14(2):59 - 66.
18. Mayinger B, Reh H, Hochberger J, Hahn EG. Endoscopic photodynamic diagnosis: Oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions. Gastrointest Endosc 1999;50(2):242-6.
19. Kriegmair M, Zaak D, Knuechel R, Baumgartner R, Hofstetter A. 5-Aminolevulinic acid-induced fluorescence endoscopy for the detection of lower urinary tract tumors. Urol Int 1999;63(1):27-31.
20. Leunig A, Betz CS, Mehlmann M, et al. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope 2000;110(1):78-83.
21. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B 1990;6(1-2):143-8.
22. Major AL, Rose GS, Chapman CF, et al. In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA). Gynecol Oncol 1997;66(1): 122-32.
23. Hornung R, Major AL, McHale M, et al. In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model. J Am Assoc Gynecol Laparosc 1998;5(2):141-8.
24. Rose GS, Tocco LM, Granger GA, et al. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol 1996;175(3 Pt 1):593-9.
25. Kessel D. Photodynamic Therapy of Neoplastic Disease. Boca Raton, FL: CRC Press, 1990.
26. Mang TS MC, Castillio N, Potter WR. Fluorescence detection of occult non-palpable metastatsesin lymph nodes following injection of low doses of Photofrin II. SPIE Proc 1988.
27. Mang TS, McGinnis C, Liebow C, Nseyo UO, Crean DH, Dougherty TJ. Fluorescence detection of tumors. Early diagnosis of microscopic lesions in preclinical studies. Cancer 1993;71(1):269-76.
28. DeLaney TF, Sindelar WF, Tochner Z, et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys 1993;25(3):445-57.
29. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79(12):2282-308.
30. Steinbach P, Kriegmair M, Baumgartner R, Hofstadter F, Knuchel R. Intravesical instillation of 5-aminolevulinic acid: The fluorescent metabolite is limited to urothelial cells. Urology 1994;44(5):676-81.
31. Markman M. Phase 3 randomized trial of 12 versus 3 months of single agent paclitaxel in patient with advanced ovarian cancer who attained a clinically-defined complete response to platinum/paclitaxel-based chemotherapy: A southwest oncology group and gynecologic oncology group trial. SGO Plenary Presentation 2002; 33rd Annual Meeting, Society of Gynecologic Oncology.